Kamada Ltd. - Ordinary Shares (NQ:KMDA)

Kamada (NASDAQ:KMDA) raised its 2026 revenue and adjusted EBITDA guidance after reporting double-digit third-quarter growth, as demand increased for its KEDRAB rabies treatment and other products. On...

Kamada Q3 Earnings Call Highlights ↗

November 09, 2026

Performance

52-Week Range 12.1% below 52-week high

8.221

6.5952W Low 9.3552W High

1 Week

6.771W Low 8.151W High

Kamada Ltd. - Ordinary Shares (KMDA) traded between $6.59 and $9.35 over the past 52 weeks and last traded at $8.22, 12.1% below its 52-week high. Over the past week it ranged between $6.77 and $8.15.

Past 12 Months

+19.7%

+4.9%

+19.5%

+4.6%

+16.9%

+16.4%

1W +$1.35

1M +$0.38

3M +$1.34

6M +$0.36

YTD +$1.19

1Y +$1.16

KMDA was +16.4% over the past year, +4.6% over six months, +16.9% year to date, +19.7% in the last week.

12 Months vs Market

KMDA

+16.4%

DIA

+9.7%

SPY

+11.4%

QQQ

+11.1%

IWM

+15.1%

Over the past 12 months KMDA returned +16.4% versus DIA (Dow) +9.7%, SPY (S&P 500) +11.4%, QQQ (Nasdaq 100) +11.1% and IWM (Russell 2000) +15.1%.

Volume & Liquidity 0.41× 3-mo avg

Today 56,640 3-mo avg 139.6K

171.7K

105.6K

139.6K

94.3K

YTD

83.1K

83.4K

KMDA most recently traded 56,640 shares against a 3-month average daily volume of 139.6K.

More News

Kamada Targets $205M Revenue as Plasma Therapies, Kedrab Demand Fuel Growth ↗

September 27, 2026

Kamada Ltd (NASDAQ:KMDA) Reports Record 2025 Results Despite Q4 Earnings Miss ↗

March 11, 2026

Via Chartmill

Earnings Scheduled For November 10, 2025 ↗

November 10, 2025

Via Benzinga

An Overview of Kamada's Earnings ↗

November 07, 2025

Via Benzinga

An Overview of Kamada's Earnings ↗

August 12, 2025

Via Benzinga

Kamada (KMDA) Q2 2026 Earnings Call Transcript ↗

August 19, 2026

Kamada Q2 Earnings Call Highlights ↗

August 12, 2026

Kamada (KMDA) Q1 2026 Earnings Transcript ↗

May 13, 2026

Kamada Q1 Earnings Call Highlights ↗

May 13, 2026

Kamada Targets 13% Revenue Growth And 23% Adjusted EBITDA Growth In 2026 Driven By Its Diverse Commercial Portfolio

January 13, 2026

Kamada Targets 13% Revenue Growth And 23% Adjusted EBITDA Growth In 2026 Driven By Its Diverse Commercial Portfolio

January 13, 2026

Kamada Reports Strongest Quarter For The Year In Q3, With Over 30% Profitability Increase Year-Over-Year

November 18, 2025

Kamada Reports Strongest Quarter For The Year In Q3, With Over 30% Profitability Increase Year-Over-Year

November 18, 2025

Kamada (KMDA) Q3 2025 Earnings Call Transcript ↗

November 10, 2025

KAMADA LTD (NASDAQ:KMDA) Reports Mixed Q3 2025 Results with Revenue Beat and Pre-Market Surge ↗

November 10, 2025

Via Chartmill

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 01, 2025

Via Benzinga

KAMADA LTD (NASDAQ:KMDA) Reports Mixed Q2 2025 Earnings with Strong EPS Beat and Raised Profitability Guidance ↗

August 13, 2025

Via Chartmill

Kamada Q1 Results: Double-Digit Growth, Company Reiterates Guidance As It Hits Multiple Milestones Including Plasma Business Expansion

June 11, 2025

Kamada Q1 Results: Double-Digit Growth, Company Reiterates Guidance As It Hits Multiple Milestones Including Plasma Business Expansion

June 11, 2025

Kamada Wants To Do More For Organ Transplant Patients, Increases Efforts To Build Awareness Of Its CMV Treatment CYTOGAM

June 06, 2025

Kamada Wants To Do More For Organ Transplant Patients, Increases Efforts To Build Awareness Of Its CMV Treatment CYTOGAM

Earnings Scheduled For August 13, 2025 ↗

August 13, 2025

Via Benzinga

June 06, 2025